Terminated NA INTERVENTIONAL 2-arm NCT00510198

Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure (PRECEDE-HF)

PRECEDE-HF -Prospective, Randomized Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Conditions Congestive Heart Failure

Interventions Cardiac Compass with OptiVol Fluid Status Monitoring Standard of Care alone (clinical assessment)

Updated 9 times since 2017 Last updated: Mar 18, 2019 Started: Oct 31, 2007 Primary completion: Apr 30, 2009 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study enrollment significantly below protocol expectation

Other terminated trials from Medtronic Cardiac Rhythm and Heart Failure

See all terminations from Medtronic Cardiac Rhythm and Heart Failure

Other Congestive Heart Failure trials with similar outcome

Browse all Congestive Heart Failure trials

This NA trial investigates Congestive Heart Failure and is currently terminated or withdrawn. Medtronic Cardiac Rhythm and Heart Failure leads this study, which shows 9 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Dec 2021 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Dec 2021 [monthly]

Terminated NA

▶ Show 4 earlier versions

May 2019 — Jan 2021 [monthly]

Terminated NA
Jun 2018 — May 2019 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Albany, United States , Anchorage, United States , Atlanta, United States , Austin, United States , Berkeley, United States , Cleveland, United States , Colorado Springs, United States , Columbus, United States , Doylestown, United States and 23 more locations